Cempra Inc.


Company Update (NASDAQ:CEMP): Cempra Inc Withdraws Solithromycin Marketing Authorization Application in Europe

Cempra Inc (NASDAQ:CEMP) announced that the company has withdrawn its marketing authorization application (MAA) seeking European Medicines Agency (EMA) approval of oral capsule …

Stock Update (NASDAQ:CEMP): Cempra Inc Retains Morgan Stanley to Lead Review of Strategic Business Options

Cempra Inc (NASDAQ:CEMP) announced that the company has retained Morgan Stanley & Co. LLC as financial advisor to the company and to lead …

Tuesday’s Market Insights: Castle Brands Inc (ROX), Seadrill Ltd (SDRL), Cempra Inc (CEMP)

Castle Brands Inc (NYSEMKT:ROX) shares skyrocketed over 40% after the premium branded spirits company announced an agreement to supply Goslings Stormy Ginger Beer …

Company Update (NASDAQ:CEMP): Here’s Why Cempra Inc Shares Crashing 15%

Cempra Inc (NASDAQ:CEMP) investors are running for the hills after the drug maker disclosed a clinical setback in its financial results today, saying …

Roth Capital Gets Bullish on Cempra Inc (CEMP) Following Phase 3 Trial Success

Cempra Inc (NASDAQ:CEMP) shares are rising close to 6% today on back of the biotech firm’s reveal that Phase 3 data read-outs in …

Cempra Inc (CEMP) Shares Jump as Fusidic Acid Gets Closer to FDA Approval

Investors in Cempra Inc (NASDAQ:CEMP) should be smiling from ear to ear this morning following the news that the drug maker achieved positive topline …

Cantor Sees CAPB Advantage for Paratek Pharmaceuticals Inc (PRTK) in Wake of Cempra Inc (CEMP) CRL Setback

Cantor analyst Chiara Russo is liking the odds for Paratek Pharmaceuticals Inc (NASDAQ:PRTK) after Cempra Inc (NASDAQ:CEMP) received a Complete Response Letter (CRL) …

CRL Jeopardizes Cempra Inc (CEMP) Pneumonia Antibiotic Program: Cowen

Cempra Inc (NASDAQ:CEMP) shares collapsed 57% yesterday after the firm received a Complete Response Letter (CRL) from the FDA for its pipeline drug …

Stock Update (NASDAQ:CEMP): Cempra Inc Shares Crash 28%; Here’s Why

Cempra Inc (NASDAQ: CEMP), announced that the company has received a Complete Response Letter (CRL) from the U.S.

SunTrust Downgrades Cempra Inc (CEMP) Amid Manufacturing Issues; Shares Fall 8%

SunTrust analyst Edward Nash has left the sidelines, downgrading his rating from a Hold to a Sell on Cempra Inc (NASDAQ:CEMP). Nash notes he expects the …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts